02 Apr 2020 --- Royal DSM has completed its €765 million (US$826 million) acquisition of Glycom, which is a major supplier of human milk oligosaccharides (HMOs). DSM states that this move enables it to further its position in the Early Life Nutrition and Dietary Supplement space. Outi Armstrong, Global Marketing Communications in Human Nutrition & Health at DSM, tells NutritionInsight that Glycom will become one of DSM’s many operating units during integration to ensure that DSM maximizes sales and cost synergies.
